CBU
DGX icon

CIBC Bank USA’s Quest Diagnostics DGX Stock Holding History

CIBC Bank USA’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$926K Hold
8,672
– – 0.12% 112
2019
Q3 		$929K Buy
8,672
+546
+7% +$56.1K 0.13% 101
2019
Q2 		$828K Buy
8,126
+405
+5% +$38.9K 0.12% 111
2019
Q1 		$694K Buy
7,721
+3
+0% +$260 0.1% 117
2018
Q4 		$642K Buy
7,718
+558
+8% +$52.3K 0.1% 110
2018
Q3 		$772K Sell
7,160
-80
-1% -$8.77K 0.11% 106
2018
Q2 		$796K Buy
7,240
+1,125
+18% +$117K 0.11% 105
2018
Q1 		$613K Buy
6,115
+1,980
+48% +$203K 0.08% 130
2017
Q4 		$408K Buy
+4,135
New +$392K 0.05% 176

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC Bank USA's DGX Position: Q4 2019 in Review

CIBC Bank USA held its Quest Diagnostics (DGX) position steady in Q4 2019 at 8,672 shares worth $926K. The position accounts for 0.12% of the portfolio, ranked #112.

CIBC Bank USA first reported a position in DGX in Q4 2017 and has held it in 9 quarters since. The position peaked at $929K in Q3 2019. 711 funds tracked by Wall St. Rank hold DGX as of Q4 2019.

  • CIBC Bank USA held 8,672 shares of Quest Diagnostics worth $926K as of Q4 2019.
  • CIBC Bank USA left its Quest Diagnostics share count unchanged in Q4 2019.
  • Quest Diagnostics made up 0.12% of CIBC Bank USA's portfolio in Q4 2019, its #112 holding.
  • CIBC Bank USA first reported a position in Quest Diagnostics in Q4 2017 and has held it in 9 quarters since.
  • CIBC Bank USA's Quest Diagnostics position peaked at $929K in Q3 2019.
  • 711 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2019.

Based on CIBC Bank USA's 13F filing for Q4 2019, filed 29 Jan 2020.